Your session is about to expire
← Back to Search
LVAD Implant
The ARIES HeartMate 3 Pump IDE Study
N/A
Waitlist Available
Research Sponsored by Abbott Medical Devices
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 years post implant
Summary
This trial looked at whether adding aspirin to a vitamin K antagonist improved outcomes in heart failure patients.
Eligible Conditions
- Heart Failure
- Congestive Heart Failure
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 3 years post implant
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 years post implant
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Non-Inferiority Primary Endpoint
Secondary study objectives
Rate of Bleeding Rates
Hemorrhage
Rate of Non-surgical Major Thrombotic Events
+3 moreOther study objectives
Economic Cost Implications
Rate of Rehospitalization
The Hemocompatibility Score (HCS)
Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: Active ArmActive Control2 Interventions
LVAD Patients on the active arm will be given 100mg Aspirin
Group II: Placebo ArmPlacebo Group2 Interventions
LVAD Patients on the placebo arm will be given placebo medication
Find a Location
Who is running the clinical trial?
Abbott Medical DevicesLead Sponsor
652 Previous Clinical Trials
416,209 Total Patients Enrolled
126 Trials studying Heart Failure
52,123 Patients Enrolled for Heart Failure
Poornima Sood, MD, MBAStudy DirectorClinical Program Director
7 Previous Clinical Trials
4,109 Total Patients Enrolled
6 Trials studying Heart Failure
4,100 Patients Enrolled for Heart Failure